Clinical trial
Efficacy And Safety Of Sunitinib In Women With Advanced Breast Cancer
NCT00471276 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00471276 |
|---|---|
| Title | Efficacy And Safety Of Sunitinib In Women With Advanced Breast Cancer |
| Official title | A Phase II Study Of Sunitinib Malate Single Agent For The Treatment Of Women With Advanced Breast Cancer |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Drug |
| Interventions | sunitinib |
| Enrollment | 83 |
| Start date | Aug 1, 2007 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | May 9, 2007 |
| Last update posted | Jul 25, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: